Data as of Dec 19
| -0.25 / -2.09%|
The 8 analysts offering 12-month price forecasts for Momenta Pharmaceuticals Inc have a median target of 16.00, with a high estimate of 18.00 and a low estimate of 12.50. The median estimate represents a +36.52% increase from the last price of 11.72.
The current consensus among 8 polled investment analysts is to Buy stock in Momenta Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.